General Information of the Compound
| Compound ID |
CP0396522
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(4-bromophenyl)-2-[5-[(3-methoxyphenyl)methyl]-6-oxo-3-propan-2-ylpyridazin-1-yl]acetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H24BrN3O3
|
||||||||||||||||||
| Molecular Weight |
470.367
|
||||||||||||||||||
| Canonical SMILES |
COc1cccc(Cc2cc(nn(CC(=O)Nc3ccc(Br)cc3)c2=O)C(C)C)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H24BrN3O3/c1-15(2)21-13-17(11-16-5-4-6-20(12-16)30-3)23(29)27(26-21)14-22(28)25-19-9-7-18(24)8-10-19/h4-10,12-13,15H,11,14H2,1-3H3,(H,25,28)
Show/Hide
|
||||||||||||||||||
| InChIKey |
IJHCATOAXCRMJB-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02015, fMet-Leu-Phe receptor
Protein ID: PT00605, FML2_HUMAN
Protein ID: PT02590, N-formyl peptide receptor 2